{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:18:55Z","timestamp":1787642335165,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canrad.2026.104802","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:57:49Z","timestamp":1771865869000},"page":"104802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy for liver tumours\u2b51"],"prefix":"10.1016","volume":"30","author":[{"given":"Marin","family":"Guigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Jaksic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-6329","authenticated-orcid":false,"given":"Emmanuel","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0425","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canrad.2011.06.005","article-title":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique h\u00e9patique par CyberKnife\u00ae\u00a0: l\u2019exp\u00e9rience lilloise","volume":"16","author":"Dewas","year":"2012","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0430","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","article-title":"Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma","volume":"115","author":"Huertas","year":"2015","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104802_bib0435","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.canrad.2019.07.159","article-title":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique h\u00e9patique\u00a0: particularit\u00e9s cliniques et implications techniques, r\u00e9sultats. Quelle machine pour quelle situation\u00a0?","volume":"23","author":"Riou","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2026.104802_bib0440","series-title":"Th\u00e9saurus national de canc\u00e9rologie digestive (TNCD)\u00ae","article-title":"Carcinome h\u00e9patocellulaire","author":"Blanc","year":"2015"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0445","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2026.104802_bib0450","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/bjs.8915","article-title":"Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria","volume":"99","author":"Lim","year":"2012","journal-title":"Br J Surg"},{"issue":"37","key":"10.1016\/j.canrad.2026.104802_bib0455","doi-asserted-by":"crossref","first-page":"e8043","DOI":"10.1097\/MD.0000000000008043","article-title":"Prognostic impact of surgical margin in patients with hepatocellular carcinoma: a meta-analysis","volume":"96","author":"Zhong","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.canrad.2026.104802_bib0460","doi-asserted-by":"crossref","first-page":"S1458","DOI":"10.1016\/j.annonc.2022.10.107","article-title":"71MO randomized phase II study of adjuvant radiotherapy after curative resection of hepatocellular carcinoma with narrow margin (\u22641cm) (RAISE)","volume":"33","author":"Kuang","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2026.104802_bib0465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2018.12.013","article-title":"Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma","volume":"131","author":"Kim","year":"2019","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2026.104802_bib0470","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/lt.23439","article-title":"Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation","volume":"18","author":"O\u2019Connor","year":"2012","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0475","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13014-017-0899-4","article-title":"Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable hepatocellular carcinoma","volume":"12","author":"Moore","year":"2017","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104802_bib0480","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2026.104802_bib0485","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.clon.2023.07.002","article-title":"Therapeutic outcome of stereotactic body radiotherapy for small hepatocellular carcinoma lesions \u2013\u00a0a systematic review and network meta-analysis","volume":"35","author":"Li","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0490","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/s12885-024-12504-2","article-title":"A randomised controlled trial of standard of care versus radioablation in early stage hepatocellular carcinoma (SOCRATES HCC)","volume":"24","author":"Wigg","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2026.104802_bib0495","series-title":"Evaluation of stereotactic body radiotherapy as a bridge therapy for hepatocellular carcinoma patients enlisted for liver transplantation (TRANSRAD-01). NCT06218420","author":"Goumard","year":"2024"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0500","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2005.04.009","article-title":"A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma","volume":"129","author":"Shiina","year":"2005","journal-title":"Gastroenterology"},{"issue":"6\u20137","key":"10.1016\/j.canrad.2026.104802_bib0505","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.canrad.2017.07.036","article-title":"Dose constraints to organs at risk for conformational and stereotactic radiotherapy: small bowel and duodenum","volume":"21","author":"Goupy","year":"2017","journal-title":"Cancer Radiother"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0510","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0515","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2016.10.024","article-title":"Central liver toxicity after SBRT: an expanded analysis and predictive nomogram","volume":"122","author":"Toesca","year":"2017","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0520","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ijrobp.2008.06.1496","article-title":"Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies","volume":"72","author":"Eccles","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.canrad.2026.104802_bib0525","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0530","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies \u2013\u00a0mature results of the French phase II RTF-1 trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0535","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1245\/s10434-007-9729-5","article-title":"Radiotherapy for hepatocellular carcinoma: an overview","volume":"15","author":"Krishnan","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0540","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2008.12.004","article-title":"Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy","volume":"286","author":"Merle","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canrad.2026.104802_bib0545","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1748-717X-8-249","article-title":"Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters","volume":"8","author":"Jung","year":"2013","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0550","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-017-0851-7","article-title":"Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma","volume":"12","author":"Gkika","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104802_bib0555","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.12659\/MSM.895548","article-title":"Improvement of survival rate for patients with hepatocellular carcinoma using transarterial chemoembolization in combination with three-dimensional conformal radiation therapy: a meta-analysis","volume":"22","author":"Bai","year":"2016","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0560","doi-asserted-by":"crossref","first-page":"100689","DOI":"10.1016\/j.jhepr.2023.100689","article-title":"TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: a randomised controlled trial","volume":"5","author":"F\u00e9ray","year":"2023","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0565","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s12029-023-00940-5","article-title":"Stereotactic body radiation therapy with or without transarterial chemoembolization versus transarterial chemoembolization alone in early-stage hepatocellular carcinoma: a systematic review and meta-analysis","volume":"54","author":"Dumago","year":"2023","journal-title":"J Gastrointest Cancer"},{"issue":"11","key":"10.1016\/j.canrad.2026.104802_bib0570","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.3390\/curroncol29110692","article-title":"Stereotactic radiotherapy after incomplete transarterial (chemo-)embolization (TAE\\TACE) versus exclusive TAE or TACE for treatment of inoperable HCC: a phase III trial (NCT02323360)","volume":"29","author":"Comito","year":"2022","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0575","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2017.07.030","article-title":"Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer","volume":"99","author":"Joo","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.canrad.2026.104802_bib0580","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0585","first-page":"190","article-title":"Stereotactic body radiation therapy for liver metastases","volume":"5","author":"Scorsetti","year":"2014","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0590","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0595","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/bjs.6895","article-title":"Stereotactic body radiation therapy for colorectal liver metastases","volume":"97","author":"van der Pool","year":"2010","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.canrad.2026.104802_bib0600","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2005.12.039","article-title":"Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study","volume":"23","author":"Berber","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2026.104802_bib0605","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/0284186X.2013.766362","article-title":"Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases","volume":"52","author":"Stintzing","year":"2013","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0610","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4143\/crt.2021.674","article-title":"Radiofrequency ablation versus stereotactic body radiation therapy in the treatment of colorectal cancer liver metastases","volume":"54","author":"Yu","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0615","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijrobp.2017.12.014","article-title":"Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases","volume":"100","author":"Jackson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.canrad.2026.104802_bib0620","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S1470-2045(24)00438-8","article-title":"Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study","volume":"25","author":"Dawson","year":"2024","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0625","first-page":"575","article-title":"Chemoembolization in colorectal liver metastases: the rebirth","volume":"34","author":"Fiorentini","year":"2014","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0630","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/cam4.1948","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: practice patterns, dose selection and factors impacting survival","volume":"8","author":"Robbins","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0635","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","article-title":"External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline","volume":"12","author":"Apisarnthanarax","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0640","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13014-021-01778-6","article-title":"Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study","volume":"16","author":"Su","year":"2021","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0645","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2023.08.015","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"118","author":"Bae","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0650","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local control after stereotactic body radiation therapy for liver tumors","volume":"110","author":"Ohri","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2026.104802_bib0655","first-page":"e8675","article-title":"Stereotactic ablative radiotherapy fractionation for hepatocellular carcinoma in the United States","volume":"12","author":"Sheth","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0660","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0665","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1245\/s10434-010-1405-5","article-title":"Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases","volume":"18","author":"Rule","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0670","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ijrobp.2010.12.047","article-title":"Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?","volume":"81","author":"Vautravers-Dewas","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2026.104802_bib0675","first-page":"45","article-title":"High versus low dose stereotactic body radiation therapy for hepatic metastases","volume":"20","author":"Kok","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0680","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1245\/s10434-015-4579-z","article-title":"A phase I dose-escalation trial of single-fraction stereotactic radiation therapy for liver metastases","volume":"23","author":"Meyer","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0685","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5582\/bst.2018.01261","article-title":"Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: an overview of current evidence according to the different target population","volume":"13","author":"Han","year":"2019","journal-title":"Biosci Trends"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0690","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.semradonc.2011.05.002","article-title":"Radiation therapy for hepatocellular carcinoma","volume":"21","author":"Feng","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104802_bib0695","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1748-717X-9-18","article-title":"Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients","volume":"9","author":"Wang","year":"2014","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0700","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0360-3016(93)90428-X","article-title":"Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol","volume":"27","author":"Russell","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2026.104802_bib0705","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canrad.2014.05.009","article-title":"Stereotactic body radiation therapy for liver tumors","volume":"18","author":"Maingon","year":"2014","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0710","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13014-019-1300-6","article-title":"Clinical impact of removing respiratory motion during liver SABR","volume":"14","author":"Gargett","year":"2019","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104802_bib0715","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejmp.2014.05.003","article-title":"The effectiveness of gadolinium MRI to improve target delineation for radiotherapy in hepatocellular carcinoma: a comparative study of rigid image registration techniques","volume":"30","author":"Yang","year":"2014","journal-title":"Phys Med"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0720","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijrobp.2010.10.032","article-title":"Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases","volume":"82","author":"M\u00e9ndez Romero","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0725","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.12121698","article-title":"New OPTN\/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma","volume":"266","author":"Wald","year":"2013","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0730","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijrobp.2009.01.057","article-title":"Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume","volume":"76","author":"Wang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0735","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijrobp.2009.03.058","article-title":"Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy","volume":"75","author":"Case","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0740","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.radonc.2007.07.021","article-title":"Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT","volume":"84","author":"Xi","year":"2007","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0745","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canrad.2008.09.011","article-title":"Dosimetric impact of breath-hold in the treatment of hepatocellular carcinoma by conformal radiation therapy","volume":"13","author":"Kubas","year":"2009","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0750","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canrad.2023.04.008","article-title":"Stereotactic body radiation therapy for liver metastases in oligometastatic disease","volume":"28","author":"Jaksic","year":"2024","journal-title":"Cancer Radiother"},{"issue":"3 Suppl.","key":"10.1016\/j.canrad.2026.104802_bib0755","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0760","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semradonc.2023.10.006","article-title":"The use of MR-guided radiation therapy for liver cancer","volume":"34","author":"Prime","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2026.104802_bib0765","doi-asserted-by":"crossref","first-page":"109912","DOI":"10.1016\/j.radonc.2023.109912","article-title":"A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors","volume":"189","author":"Bordeau","year":"2023","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0770","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/jcm12031183","article-title":"Stereotactic MR-guided radiotherapy for liver metastases: first results of the Montpellier prospective registry study","volume":"12","author":"Bordeau","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.canrad.2026.104802_bib0775","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/j.ijrobp.2023.06.1280","article-title":"MRI Guided adaptive radiotherapy (MRgART) in primary and metastatic liver lesions","volume":"117","author":"Chong","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6\u20137","key":"10.1016\/j.canrad.2026.104802_bib0780","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.canrad.2022.06.031","article-title":"Stereotactic body radiotherapy of primary liver tumours: Indications and new techniques","volume":"26","author":"Bordeau","year":"2022","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0785","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s13246-024-01440-x","article-title":"Dosimetric comparison of proton therapy and CyberKnife in stereotactic body radiation therapy for liver cancers","volume":"47","author":"Shyllon","year":"2024","journal-title":"Phys Eng Sci Med"},{"issue":"5","key":"10.1016\/j.canrad.2026.104802_bib0790","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.21873\/anticanres.17029","article-title":"Proton beam radiotherapy as a curative alternative to radiofrequency ablation for newly diagnosed hepatocellular carcinoma","volume":"44","author":"Seo","year":"2024","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0795","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0800","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2023.09.047","article-title":"Proton beam therapy for hepatocellular carcinoma: multicenter prospective registry study in Japan","volume":"118","author":"Mizumoto","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0805","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12876-023-02897-y","article-title":"Proton beam therapy for hepatocellular carcinoma with bile duct invasion","volume":"23","author":"Iizumi","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.canrad.2026.104802_bib0810","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jrr\/rrad066","article-title":"The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients","volume":"64","author":"Yamaguchi","year":"2023","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2026.104802_bib0815","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2022.09.003","article-title":"A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases","volume":"176","author":"Kim","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0820","first-page":"1","article-title":"ICRU report 62, prescribing, recording and reporting photon beam therapy (supplement to ICRU 50)","volume":"os-32","author":"Anon.","year":"1999","journal-title":"J ICRU"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0825","first-page":"1","article-title":"ICRU report 83, prescribing, recording, and reporting Intensity-Modulated Photon-Beam Therapy (IMRT)","volume":"10","author":"Anon.","year":"2010","journal-title":"J ICRU"},{"issue":"3","key":"10.1016\/j.canrad.2026.104802_bib0830","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: statement from the DEGRO\/DGMP work ing group stereotactic radiotherapy and radiosurgery","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2026.104802_bib0835","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"Delineation of organs at risk and dose constraints","volume":"20 Suppl.","author":"No\u00ebl","year":"2016","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.canrad.2026.104802_bib0840","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321826000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:19:47Z","timestamp":1787638787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321826000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1278321826000053"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104802","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for liver tumours\u2b51","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2026.104802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104802"}}